Fertility treatment and risk of non-gynecological cancer: a systematic review
Archives of Gynecology and Obstetrics · 02.01.2026 · 313 (1)
DOI: 10.1007/s00404-025-08264-4 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Archives of Gynecology and Obstetrics, online erschienen am 02.01.2026. Verfasst von SoYoung Kim und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health, Korea University, Seoul, 02841, Republic of Korea. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Colorectal Neoplasms, Lung Neoplasms, Stomach Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
PURPOSE: Evidence on the relationship between fertility treatment and non-gynecologic cancers remains limited. This study synthesizes available research on the association between fertility treatments and the risk of non-gynecologic cancers in women with infertility. METHODS: We systematically searched MEDLINE, EMBASE, and the Cochrane Library for studies involving women with infertility who received fertility treatment, compared with untreated women or the general population. Primary outcomes included the incidence of thyroid, colorectal, gastric, and lung cancers. Subgroup analyses were conducted by type of ovarian stimulation drug, in vitro fertilization (IVF) status, parity, length of follow-up, and choice of reference group. RESULTS: Fifteen studies met the inclusion criteria. Fertility treatment was positively, though imprecisely, associated with thyroid cancer (relative risk [RR] = 1.22; 95% confidence interval [CI]: 0.95-1.57). No increased risk of colorectal cancer was observed among treated women. Clomiphene citrate use was associated with a higher risk of thyroid cancer (RR = 1.28; 95% CI: 1.07-1.54) and a lower risk of colorectal cancer (RR = 0.79; 95% CI: 0.65-0.96). CONCLUSION: Fertility medications may increase the risk of thyroid cancer while potentially reducing the risk of colorectal cancer in women with infertility. Given the small number of studies and their heterogeneity, these findings should be interpreted cautiously. Further research is needed to clarify these associations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Public Health, Korea University, Seoul, 02841, Republic of Korea.
- National Evidence-Based Healthcare Collaborating Agency, Seoul, 04933, Republic of Korea.
- Department of Preventive Medicine, Korea University College of Medicine, Seoul, 02841, Republic of Korea.
- Department of Preventive Medicine, Institute for Evidence-Based Medicine, Korea University College of Medicine, Seoul, Republic of Korea.
- Department of Preventive Medicine, Korea University College of Medicine, Seoul, 02841, Republic of Korea. seungah@korea.ac.kr.
- Research and Management Center for Health Risk of Particulate Matter, Korea University, Seoul, 02841, Republic of Korea. seungah@korea.ac.kr.
ORCID-Profile: Seung-Ah Choe
Förderung
- National Research Foundation of Korea
Zitieren
APA
Kim, S., Mo, J. A., Kim, H. J., & Choe, S. A. (2026). Fertility treatment and risk of non-gynecological cancer: a systematic review. Archives of Gynecology and Obstetrics, 313(1). https://doi.org/10.1007/s00404-025-08264-4
Vancouver
Kim S, Mo JA, Kim HJ, Choe SA. Fertility treatment and risk of non-gynecological cancer: a systematic review. Archives of Gynecology and Obstetrics. 2026;313(1). doi:10.1007/s00404-025-08264-4
BibTeX
@article{Kim2026,
author = {Kim, SoYoung and Mo, Jin-A and Kim, Hyun-Jung and Choe, Seung-Ah},
title = {Fertility treatment and risk of non-gynecological cancer: a systematic review},
journal = {Archives of Gynecology and Obstetrics},
year = {2026},
volume = {313},
number = {1},
doi = {10.1007/s00404-025-08264-4}
}
EUVIMED